Regenerative Medical Technology Group Inc. (RMTG)

RMTG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	0	0	0	0	3	0
Market Cap Growth	-21.13%	291.82%	-61.42%	-92.72%	1006.82%	106.29%
Enterprise Value	18	19	16	13	13	2
Last Close Price	0.03	0.03	0.01	0.02	0.27	0.03
PS Ratio	0.08	0.09	0.04	0.16	7.42	5.33
PB Ratio	-0.01	-0.01	0.00	-0.02	-0.48	-0.05
P/FCF Ratio	-	0.56	-	-	-	-
P/OCF Ratio	-	0.42	-	-	-	-
EV/Sales Ratio	3.55	4.72	6.79	8.62	29.93	35.62
EV/EBITDA Ratio	89.06	54.76	-	-	-	-
EV/EBIT Ratio	-	145.32	-	-	-	-
EV/FCF Ratio	-23.84	30.51	-	-	-	-
Debt / Equity Ratio	-0.62	-0.73	-0.81	-1.26	-1.98	-0.91
Debt / EBITDA Ratio	92.99	56.65	-	-	-	-
Debt / FCF Ratio	-	31.56	-	-	-	-
Net Debt / Equity Ratio	-0.58	-0.69	-0.79	-1.13	-1.54	-0.91
Net Debt / EBITDA Ratio	416.84	53.35	-43.22	-16.03	-1.06	-13.18
Net Debt / FCF Ratio	-23.31	29.72	-21.27	-10.28	-1.05	-17.77
Asset Turnover	1.30	1.23	0.44	0.18	0.09	0.45
Quick Ratio	0.08	0.04	0.03	0.14	0.71	0.05
Current Ratio	0.09	0.04	0.03	0.14	0.72	0.05
Return on Assets (ROA)	-1.82%	2.49%	-8.05%	-7.15%	-128.86%	-221.44%
Return on Capital Employed (ROCE)	0.90%	-0.50%	3.60%	25.40%	-193.00%	62.80%
Earnings Yield	-1790.54%	-1556.68%	-10759.89%	-2329.11%	-396.60%	-2008.60%
FCF Yield	-190.46%	177.77%	-882.39%	-555.15%	-304.07%	-109.96%
Buyback Yield / Dilution	-0.22%	-0.68%	-1.86%	-6.42%	-22.91%	-76.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.